Recently, the work was completed by the group of Prof. Sheng Meng from the Institute of Physics, Chinese Academy of Sciences, and Beijing National Research Center for Condensed Matter Physics. By ...

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

The proposals for Dowlais Primary School and Cyfarthfa High School will go before cabinet next week with new autism spectrum disorder bases proposed ...

Recently, the work was completed by the group of Prof. Sheng Meng from the Institute of Physics, Chinese Academy of Sciences, and Beijing National ...

Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), a leader in RNA interference (RNAi) therapeutics, stands at a pivotal juncture as it seeks to capitalize on the burgeoning market for ...

The company is fueling its growth through transformative initiatives, such as the Phase 3+ Expansion at Island Gold and the ambitious Lynn Lake project in Manitoba. On Nov. 6, Alamos Gold delivered an ...

It remains unclear whether the ISA will grant approval. Liquidity also worries me, as it is uncertain whether the company will be able to finance its operations until the commercial phase begins. With ...

Zilebesiran (formerly ALN-AGT) is one of a new breed of gene-silencing ... Zilebesiran is currently in a phase 2 trial in mild-to-moderate hypertension called KARDIA-1 which is due to generate ...

A target date has been revealed for the opening of a new trail on a disused railway line in Alnwick. Phase one of the ...